EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Brazilian multicenter study for the evaluation of patients' satisfaction of blood glucose self-monitoring with BGStar(®) blood glucose meter in insulinized patients with diabetes mellitus type 1 and 2



Brazilian multicenter study for the evaluation of patients' satisfaction of blood glucose self-monitoring with BGStar(®) blood glucose meter in insulinized patients with diabetes mellitus type 1 and 2



Diabetology & Metabolic Syndrome 8(1): 66-66



Diabetes mellitus (DM) is considered a global epidemic, and patient self-management education and support are critical in preventing and reducing the risk of complications. Self-monitoring of blood glucose (SMBG) is essential for care of individuals with DM, helping patients to achieve and maintain target blood glucose levels. The purpose of this study is to compare the satisfaction of insulinized DM patients on SMBG with use of investigational blood glucose meter (BGM) versus their routine device. A national, multicenter, open-label, phase 4 study was conducted on patients with type 1 or 2 DM under insulin therapy regimen, who were asked to use investigational BGM instead of their usual BGM device. The study was performed in 12 centers in Brazil for 12 weeks, with an extension period of 12 weeks. The primary endpoint was to measure the variation on the patients' level of satisfaction with investigational versus routine BGM, between visits, using a Visual Analogue Scale (VAS). Secondary endpoints addressed handling aspects, satisfaction, adherence and level of functionality and safety of investigational BGM. The study included 292 patients (36.6 % DM1 and 63.4 % DM2), mean age 50.9 years old (±17.3 years), 57.5 % females. There was statistically significant improvement in global satisfaction with investigational BGM compared with routine BGM according to VAS [mean VAS score raised from 78.8 mm (SD = 18.0) to 90.8 mm (SD = 12.2) between visits]. After 12 weeks, level of satisfaction with investigational BGM according to questionnaires was superior to routine BGM regardless of age group (p < 0.001), type of DM (p < 0.001) or insulin regimen (p < 0.001). Investigational BGM was also regarded as safe, with 10 patients (3.4 %) reporting a total of 13 adverse events during the study. Levels of satisfaction during SMBG were higher with use of investigational BGM and the device was deemed safe and easy to handle.

(PDF emailed within 0-6 h: $19.90)

Accession: 057323754

Download citation: RISBibTeXText

PMID: 27625706

DOI: 10.1186/s13098-016-0180-2



Related references

Evaluation of blood glucose fluctuation in Japanese patients with type 1 diabetes mellitus by self-monitoring of blood glucose and continuous glucose monitoring. Diabetes Research and Clinical Practice 108(2): 342-349, 2015

Compliance to self-monitoring of blood glucose among patients with type 2 diabetes mellitus and its influential factors: a real-world cross-sectional study based on the Tencent TDF-I blood glucose monitoring platform. Mhealth 3: 25-25, 2017

Immortal time bias does not invalidate the association of self-monitoring of blood glucose with better survival of patients with type 2 diabetes in the epidemiological study ROSSO (Retrolective Study: Self-monitoring of Blood Glucose and Outcome in Patients with Type 2 Diabetes). Diabetologia 54(2): 475-476, 2011

Immortal time bias and survival in patients who self-monitor blood glucose in the Retrolective Study: self-monitoring of Blood Glucose and Outcome in Patients with Type 2 Diabetes (ROSSO). Diabetologia 54(2): 308-311, 2011

Advanced meter features improve postprandial and paired self-monitoring of blood glucose in individuals with diabetes: results of the Actions with the CONTOUR Blood Glucose Meter and Behaviors in Frequent Testers (ACT) study. Diabetes Technology & Therapeutics 14(10): 851-857, 2013

Evaluation of blood glucose estimation and measurement of 24-h urine glucose as measures of mean blood glucose expressed as HbAIc in patients with insulin-dependent diabetes mellitus. Ugeskrift for Laeger 148(30): 1899-1901, 1986

Evaluation of blood glucose determination and 24-hour urinary glucose excretion as indicators of mean blood glucose as expressed by HbAIc in patients with insulin-dependent diabetes mellitus. Ugeskrift for Laeger 148(30): 1899-1901, 1986

Evaluation of the relationship between frequency of blood glucose monitoring and metabolic control in patients with Type 2 diabetes mellitus. Diabetes & Metabolism 29(Hors serie 2): 4S190-4S191, August, 2003

2008 resource guide. Blood glucose monitoring and data management systems. Before you buy a blood glucose monitor (also known as a blood glucose meter), check with your doctor and diabetes educator. Make sure the one you choose is well suited to your particular needs. Diabetes Forecast 61(1): Rg31-2, Rg34-48, 2008

Effectiveness for self-monitoring of blood sugar on blood glucose control in Turkish patients with type 2 diabetes mellitus. Medicinski Glasnik 9(2): 211-217, 2012

Interrelations between diabetes therapy, self-monitoring of blood glucose, blood glucose and non-fatal or fatal endpoints in patients with type 2 diabetes / results of a longitudinal cohort study (ROSSO 5). Arzneimittel-Forschung 57(12): 762-769, 2008

Real-time continuous glucose monitoring versus internet-based blood glucose monitoring in adults with type 2 diabetes: a study of treatment satisfaction. Diabetes Research and Clinical Practice 106(3): 481-486, 2015

Self-monitoring of blood glucose in type 1 diabetes patients with insufficient metabolic control: focused self-monitoring of blood glucose intervention can lower glycated hemoglobin A1C. Journal of Diabetes Science and Technology 3(1): 83-88, 2011

Short-term continuous glucose monitoring: effects on glucose and treatment satisfaction in patients with type 1 diabetes mellitus; a randomized controlled trial. International Journal of Clinical Practice 66(8): 741-747, 2012

Near patient testing for glycated haemoglobin in people with type 2 diabetes mellitus managed in primary care: acceptability and satisfaction; Impact of self-monitoring of blood glucose in the management of patients with non-insulin-treated diabetes: open parallel group randomized trial. Annals of Clinical Biochemistry 45(Pt 1): 114-115, 2008